Sanders to Subpoena Pharma CEOs Over Drug Pricing After Lawsuit Against Medicare Negotiations
• Sen. Bernie Sanders plans to subpoena CEOs of Johnson & Johnson and Merck to testify on drug pricing after they refused invitation • CEOs declined, offering to send other execs, concerned about direction and retaliation over lawsuit against Medicare drug pricing rules • Companies are suing to block Medicare drug price negotiations under Biden's Inflation Reduction Act • Merck suggests subpoena is retaliation for lawsuit challenging legislation • Former Trump advisor says targeting CEOs over legal lawsuit is "un-American" and they aren't best to explain pharma costs